Aurobindo Pharma on Thursday reported 84% year-on-year (YoY) rise in net profit to Rs 752 crore in the second quarter ended September 2023, led by strong sales from the US market.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
